| Trial registration number
|
NCT05694975 |
Full text link
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05694975
|
First author
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Liu Zhanguo, MD,PhD
|
Contact
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
zhguoliu@163.com
|
Registration date
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
2023-01-23
|
Recruitment status
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Recruiting
|
Study design
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
multi-center
|
Study aim
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
adults (age 18 years or older).
diagnosed with covid-19 according to the diagnosis and clinical management of covid-19. (trial version 10).
severe and critical ill patients with covid-19.
patients who voluntarily participate in the study and sign the informed consent form.
|
Exclusion criteria
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
patients with a history of allergy to vc.
pregnant or lactating women.
patients with end-stage malignant tumour.
patients with an expected survival duration of less than 24 hours.
patients with cerebral hernia and severe craniocerebral injury.
patients with diabetes.
patients with a previous history of g-6-pd deficiency.
|
Number of arms
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Zhujiang Hospital
|
Inclusion age min
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
China
|
Type of patients
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Severe/critical disease at enrollment
|
Severity scale
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
7: Severe/critical disease at enrollment
|
Total sample size
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
608
|
primary outcome
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
The 28-day mortality or persistent organ dysfunctionat day 28.
|
Notes
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Phase 2/Phase 3
|
Arms
Last imported at : Jan. 24, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "nan", "treatment_id": 1369, "treatment_name": "Vitamin c", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|